Russia starts production of CoviVac vaccine against COVID-19 - Chemical Industry - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

Russia starts production of CoviVac vaccine against COVID-19

MOSCOW, Mar 25 (PRIME) -- Russia has started production of its third vaccine against the coronavirus CoviVac on the premises of the Chumakov center, the Science and Higher Education Ministry said in a statement Thursday.

The vaccine was registered in February, and 775,000 doses can be produced in March–June, no less than 10 million in 2021.

Russian company Nanolek could become an industrial partner of the Chumakov center in the vaccine production, Science and Higher Education Minister Valery Falkov said. "This is Nanolek," Falkov said referring to negotiations between the entities.

End

25.03.2021 12:10
 
 
Share |
To report an error select text and press Ctrl+Enter
 
 
Central Bank Official Rate
1W 1M 1Y
USD
EUR 90.4602 -1.7705 17 apr
USD 75.5535 -1.4273 17 apr
Stock Market Indices
1D 1W 1M 1Y
MICEX
micex 3587.17 +0.52 17:14 16 apr
Stock Quotes in RUR
1D 1W 1M 1Y
GAZP
gazp 234.63 -0.29 23:49 16 apr
lkoh 6054.50 -1.30 23:49 16 apr
rosn 556.50 +0.80 23:49 16 apr
sber 283.72 -1.20 23:49 16 apr
MICEX Ruble Trading
1D 1W 1M 1Y
USDTD
EURTD 90.9300 -1.3125 14:59 16 apr
USDTD 76.2475 +0.6525 17:44 16 apr